BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

880 related articles for article (PubMed ID: 34489933)

  • 1. Cytokine Signature Associated With Disease Severity in COVID-19.
    Guo J; Wang S; Xia H; Shi D; Chen Y; Zheng S; Chen Y; Gao H; Guo F; Ji Z; Huang C; Luo R; Zhang Y; Zuo J; Chen Y; Xu Y; Xia J; Zhu C; Xu X; Qiu Y; Sheng J; Xu K; Li L
    Front Immunol; 2021; 12():681516. PubMed ID: 34489933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
    Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
    Front Immunol; 2021; 12():691879. PubMed ID: 34163488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19.
    Ling L; Chen Z; Lui G; Wong CK; Wong WT; Ng RWY; Tso EYK; Fung KSC; Chan V; Yeung ACM; Hui DSC; Chan PKS
    Front Immunol; 2021; 12():763292. PubMed ID: 34938289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19.
    Thwaites RS; Sanchez Sevilla Uruchurtu A; Siggins MK; Liew F; Russell CD; Moore SC; Fairfield C; Carter E; Abrams S; Short CE; Thaventhiran T; Bergstrom E; Gardener Z; Ascough S; Chiu C; Docherty AB; Hunt D; Crow YJ; Solomon T; Taylor GP; Turtle L; Harrison EM; Dunning J; Semple MG; Baillie JK; Openshaw PJ;
    Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33692097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnant women infected with pandemic influenza A(H1N1)pdm09 virus showed differential immune response correlated with disease severity.
    Periolo N; Avaro M; Czech A; Russo M; Benedetti E; Pontoriero A; Campos A; Peralta LM; Baumeister E
    J Clin Virol; 2015 Mar; 64():52-8. PubMed ID: 25728079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine profiling in Iranian patients with COVID-19; association with clinical severity.
    Taghiloo S; Soltanshahi M; Aliyali M; Abedi S; Mehravaran H; Ajami A; Asgarian-Omran H
    Iran J Immunol; 2021 Mar; 18(1):54-64. PubMed ID: 33787514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and Prognostic Biomarkers of Coronavirus Disease 2019 in Children.
    Önal P; Kılınç AA; Aygün FD; Aygün F; Durak C; Akkoç G; Ağbaş A; Elevli M; Çokuğraş H
    J Trop Pediatr; 2022 Feb; 68(2):. PubMed ID: 35179604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine and chemokine profiles in the sera of COVID-19 patients with different stages of severity.
    Bourhis M; Idir A; Machraoui S; Hachimi A; Elouardi Y; Jamil O; Khallouki M; Zahlane K; Guennouni M; Hazime R; Essaadouni L; Lourhlam B; Ennaji MM; Mouse HA; Admou B; Zyad A
    Cytokine; 2024 Aug; 180():156653. PubMed ID: 38781873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Cytokine and Chemokine Profile in Relation to the Severity of Coronavirus Disease 2019 in China.
    Chi Y; Ge Y; Wu B; Zhang W; Wu T; Wen T; Liu J; Guo X; Huang C; Jiao Y; Zhu F; Zhu B; Cui L
    J Infect Dis; 2020 Aug; 222(5):746-754. PubMed ID: 32563194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of cytokine/chemokine responses for the disease severity and management in children and adult cases with COVID-19.
    Ozsurekci Y; Aykac K; Er AG; Halacli B; Arasli M; Oygar PD; Gürlevik S; Cura Yayla BC; Karakaya J; Alp A; Topeli A; Cengiz AB; Akova M; Ceyhan M
    J Med Virol; 2021 May; 93(5):2828-2837. PubMed ID: 33225509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.
    Azar MM; Shin JJ; Kang I; Landry M
    Expert Rev Mol Diagn; 2020 Nov; 20(11):1087-1097. PubMed ID: 32990479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection.
    Horspool AM; Kieffer T; Russ BP; DeJong MA; Wolf MA; Karakiozis JM; Hickey BJ; Fagone P; Tacker DH; Bevere JR; Martinez I; Barbier M; Perrotta PL; Damron FH
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33472985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Deep Look Into COVID-19 Severity Through Dynamic Changes in Blood Cytokine Levels.
    Kleymenov DA; Bykonia EN; Popova LI; Mazunina EP; Gushchin VA; Kolobukhina LV; Burgasova OA; Kruzhkova IS; Kuznetsova NA; Shidlovskaya EV; Divisenko EV; Pochtovyi AA; Bacalin VV; Smetanina SV; Tkachuk AP; Logunov DY; Gintsburg AL
    Front Immunol; 2021; 12():771609. PubMed ID: 34858428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine Elevation in Severe COVID-19 From Longitudinal Proteomics Analysis: Comparison With Sepsis.
    Ebihara T; Matsumoto H; Matsubara T; Togami Y; Nakao S; Matsuura H; Kojima T; Sugihara F; Okuzaki D; Hirata H; Yamamura H; Ogura H
    Front Immunol; 2021; 12():798338. PubMed ID: 35095877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
    Choreño-Parra JA; Jiménez-Álvarez LA; Cruz-Lagunas A; Rodríguez-Reyna TS; Ramírez-Martínez G; Sandoval-Vega M; Hernández-García DL; Choreño-Parra EM; Balderas-Martínez YI; Martinez-Sánchez ME; Márquez-García E; Sciutto E; Moreno-Rodríguez J; Barreto-Rodríguez JO; Vázquez-Rojas H; Centeno-Sáenz GI; Alvarado-Peña N; Salinas-Lara C; Sánchez-Garibay C; Galeana-Cadena D; Hernández G; Mendoza-Milla C; Domínguez A; Granados J; Mena-Hernández L; Pérez-Buenfil LÁ; Domínguez-Cheritt G; Cabello-Gutiérrez C; Luna-Rivero C; Salas-Hernández J; Santillán-Doherty P; Regalado J; Hernández-Martínez A; Orozco L; Ávila-Moreno F; García-Latorre EA; Hernández-Cárdenas CM; Khader SA; Zlotnik A; Zúñiga J
    Front Immunol; 2021; 12():593595. PubMed ID: 33995342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine Profiles Before and After Immune Modulation in Hospitalized Patients with COVID-19.
    Azmy V; Kaman K; Tang D; Zhao H; Dela Cruz C; Topal JE; Malinis M; Price CC
    J Clin Immunol; 2021 May; 41(4):738-747. PubMed ID: 33459964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients.
    Olbei M; Hautefort I; Modos D; Treveil A; Poletti M; Gul L; Shannon-Lowe CD; Korcsmaros T
    Front Immunol; 2021; 12():629193. PubMed ID: 33732251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine Signature Associated with Disease Severity in Dengue.
    Patro ARK; Mohanty S; Prusty BK; Singh DK; Gaikwad S; Saswat T; Chattopadhyay S; Das BK; Tripathy R; Ravindran B
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30626045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.